Menopause Market Sees Commercialization Outpace Evidence-Based Care in the U.S.
The U.S. menopause market is experiencing a significant surge in commercialization, with product-led marketing increasingly outpacing evidence-based medical guidance. A JAMA Network Open study, analyzing two decades of Google Trends data, revealed that commercial searches for menopause-related products rose from one in five in 2010 to one in three by 2025. The study, led by Dr. Francesca Farina of the University of Chicago, found that 'black cohosh,' a supplement with weak evidence for treating hot flashes, was the most-searched commercial term. This trend indicates a growing gap between consumer interest in commercial solutions and the scientific evidence supporting their efficacy. Physicians and medical organizations, including the American College of Obstetricians and Gynecologists (ACOG), have expressed concerns about the rise of direct-to-consumer menopause services and the potential for commercial bias in the information women receive. The ACOG has even published a consumer guide to help women identi...
